See more : LawFinance Limited (LAW.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Adynxx, Inc. (ADYX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adynxx, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Coaster International Co., Ltd. (2936.TW) Income Statement Analysis – Financial Results
- Zhejiang Wellsun Intelligent Technology Co.,Ltd. (300882.SZ) Income Statement Analysis – Financial Results
- Arshiya Limited (ARSHIYA.NS) Income Statement Analysis – Financial Results
- BlackRock, Inc. (BLQA.DE) Income Statement Analysis – Financial Results
- TheMaven, Inc. (MVEN) Income Statement Analysis – Financial Results
Adynxx, Inc. (ADYX)
About Adynxx, Inc.
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 2.22M | 19.57M | 18.24M | 15.04M | 4.79M | 1.80M | 1.23M | 1.83M | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.72M | 6.76M | 6.66M | 6.05M | 3.27M | 2.10M | 1.84M | 1.92M | 1.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 496.00K | 12.80M | 11.59M | 8.99M | 1.52M | -299.29K | -608.50K | -86.36K | -518.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 22.38% | 65.43% | 63.51% | 59.78% | 31.66% | -16.65% | -49.52% | -4.71% | -39.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 1.01M | 121.00K | 859.00K | 715.07K | 0.00 | 63.20K | 233.82K | 522.83K | 170.25K | 185.08K | 892.39K | 172.53K | 302.62K | 261.69K | 151.55K | 41.40K | 91.50K | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 5.75M | 2.34K | 2.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.03M | 1.33M | 2.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.91M | 37.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 5.75M | 28.91M | 37.13M | 35.18M | 26.16M | 11.67M | 4.05M | 3.85M | 2.03M | 1.33M | 2.06M | 2.49M | 4.25M | 2.47M | 1.25M | 1.04M | 285.92K | 165.94K | 90.88K | 130.76K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 121.00K | -2.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 5.79M | 29.03M | 37.98M | 35.90M | 26.16M | 11.73M | 4.29M | 4.38M | 2.20M | 1.51M | 2.96M | 2.68M | 4.67M | 2.82M | 1.44M | 1.10M | 377.42K | 165.94K | 90.88K | 130.76K |
Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 7.51M | 35.79M | 44.64M | 41.95M | 29.43M | 13.83M | 6.13M | 6.29M | 4.04M | 1.51M | 2.96M | 2.68M | 4.67M | 2.82M | 1.44M | 1.10M | 377.42K | 165.94K | 90.88K | 130.76K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 24.00K | 0.00 | 42.00K | 41.68K | 30.74K | 2.91K | 817.00 | 4.35K | 9.08K | 29.62K | 30.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 24.00K | 2.28M | 2.54M | 1.56M | 384.00 | 4.81K | 3.35K | 2.51K | 2.46K | 1.23K | 52.88K | 88.99K | 104.44K | 83.37K | 39.95K | 20.46K | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 331.00K | 316.00K | 3.83M | 2.87M | 1.08M | 674.23K | 647.82K | 632.69K | 624.45K | 62.50K | 7.82K | 1.72M | 6.53K | 1.07K | 261.00 | 583.00 | 1.15K | 1.16K | 578.00 | 0.00 |
EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -5.30M | -3.93M | -27.38M | -24.58M | -24.35M | -21.29M | -4.24M | -13.21M | -2.46M | -170.43K | -2.27M | -957.32K | -4.54M | -2.73M | -1.40M | -1.10M | -376.27K | -164.78K | -90.30K | -130.76K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -75.95% | -55.27% | -144.50% | -178.60% | -514.18% | -631.64% | -345.74% | -208.75% | -158.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -5.30M | -26.20M | -31.19M | -28.31M | -25.42M | -20.13M | -4.90M | -13.85M | -2.72M | -1.51M | -2.96M | -2.68M | -4.67M | -2.82M | -1.44M | -1.10M | -377.42K | -165.94K | -90.88K | -130.76K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -238.99% | -133.91% | -170.99% | -188.19% | -531.08% | -1,119.87% | -398.53% | -755.84% | -206.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -1.71M | 516.00K | 2.95M | -629.01K | -13.04K | -1.84M | 2.35K | 6.47K | -367.97K | -1.36M | -705.73K | -49.54K | -91.40K | -78.90K | 1.92K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -7.00M | -28.60M | -33.12M | -27.73M | -25.43M | -21.97M | -4.89M | -13.84M | -3.09M | -2.88M | -3.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -316.06% | -146.18% | -181.57% | -184.39% | -531.36% | -1,221.97% | -398.34% | -755.48% | -233.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 3.12M | -743.00K | -715.00K | -1.72M | 14.00K | 9.00K | 11.00K | 11.00K | 12.00K | 1.33M | 705.73K | 1.76M | -13.04K | -4.46K | -1.92K | 0.00 | -1.95K | -5.57K | -10.27K | 121.05K |
Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -8.42M | -25.71M | -28.24M | -26.02M | -25.45M | -21.98M | -4.91M | -13.85M | -3.10M | -2.85M | -3.67M | -4.44M | -4.65M | -2.81M | -1.44M | -1.10M | -375.47K | -160.36K | -80.61K | -121.05K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -379.83% | -131.39% | -154.84% | -172.97% | -531.65% | -1,222.47% | -399.24% | -756.08% | -234.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | -10.26 | -35.94 | -60.60 | -67.69 | -104.36 | -184.66 | -54.67 | -175.55 | -52.13 | -97.11 | -112.01 | -157.22 | -171.01 | -106.56 | -58.33 | -52.55 | -18.70 | -9.27 | -5.14 | -8.11 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -10.26 | -35.94 | -60.60 | -67.69 | -104.36 | -184.66 | -54.67 | -175.55 | -52.13 | -97.11 | -112.01 | -157.22 | -171.01 | -106.56 | -58.33 | -52.55 | -18.70 | -9.27 | -5.14 | -8.11 |
Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 820.57K | 715.27K | 466.09K | 384.37K | 243.82K | 119.01K | 89.73K | 78.91K | 59.43K | 29.33K | 32.74K | 28.23K | 27.22K | 26.41K | 24.61K | 21.00K | 20.08K | 17.30K | 15.70K | 14.93K |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 820.57K | 715.27K | 466.09K | 384.37K | 243.82K | 119.01K | 89.73K | 78.91K | 59.43K | 29.33K | 32.74K | 28.23K | 27.22K | 26.41K | 24.61K | 21.00K | 20.08K | 17.30K | 15.70K | 14.93K |
Source: https://incomestatements.info
Category: Stock Reports